久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

China boosts public health with vaccine and immunization progress

Xinhua | Updated: 2025-04-21 09:21
Share
Share - WeChat
This photo taken with a mobile phone shows a volunteer (R) helping Yemeni businessman Sufyan Marwan Sufyan Mohanmmed take vaccine reservation receipt for his daughter from a machine by scanning a QR code at a community health service center in Yiwu, East China's Zhejiang province, March 25, 2025. [Photo/Xinhua]

WUHAN -- China has made significant progress in vaccine development and immunization, marked by a growing portfolio of domestically produced vaccines and remarkable public health results.

These achievements were highlighted at the 2025 National Vaccines and Health Conference, held over the weekend in Wuhan, capital of Hubei Province in central China, and attended by nearly 3,000 public health officials and medical professionals.

Over the past years, China has achieved notable breakthroughs in vaccine technology. Milestones include the successful development of homegrown HPV and Ebola vaccines, as well as advances in pneumococcal conjugate vaccines against 13 types of bacteria and shingles vaccines.

Several Chinese vaccines have received prequalification from the World Health Organization, enabling their distribution in partner countries of the Belt and Road Initiative.

These advancements underscore a broader shift in China's vaccine industry -- from focusing primarily on domestic needs to increasingly contributing to the global vaccine supply chain, according to Wang Yunfu, head of the Health Commission of Hubei Province.

The global biotechnology landscape has also helped accelerate this transformation, as the participants pointed out. In recent years, breakthroughs in technologies such as mRNA platforms, viral vectors, and nanoparticle delivery systems have opened up unprecedented opportunities for vaccine research and development, significantly improving both efficiency and immune response.

Alongside scientific innovation, China has placed strong emphasis on safety and regulatory oversight. In 2019, it became the first country to implement a comprehensive vaccine administration law, followed by updated immunization standards introduced in 2023.

A nationwide traceability system has been set up, ensuring that every dose can be tracked from production to administration, enhancing transparency and public trust.

China's national immunization programs have yielded strong public health results.

The country achieved polio-free status in 2000, eliminated neonatal tetanus by 2012, and has reported no locally transmitted diphtheria cases since 2007. The prevalence of hepatitis B surface antigen among children under five declined from nearly 10 percent in 1992 to just 0.3 percent in 2020.

Routine vaccination coverage has remained above 90 percent nationwide, supported by an extensive healthcare infrastructure that ensures every township has at least one vaccination unit.

Efforts to expand access and improve service delivery remain a central priority. "Public health should be protected through more accessible and higher-quality vaccine services," said Li Bin, president of the Chinese Preventive Medicine Association, adding that this goal was reflected in the conference's theme.

For example, in Hubei, girls aged 14 are now eligible for free HPV vaccination, and immunization for newborns is being integrated into the birth registration process to ensure early and timely coverage.

Looking ahead, China is preparing to refine its immunization strategy and services further.

Health authorities are considering dynamic adjustments to the national immunization program to prioritize vaccines with high cost-effectiveness or those associated with costly diseases. In some regions, pilots may allow the use of personal health insurance accounts to cover non-mandatory vaccines, reducing out-of-pocket expenses for the public.

Digital tools will also play an increasing role in modernizing immunization services. Electronic vaccination records are being shared across provinces, while artificial intelligence (AI) is assisting with appointment scheduling. Big data platforms are improving vaccine inventory management and logistics.

Yin Zundong, head of the Immunization Program Center at the Chinese Center for Disease Control and Prevention, emphasized the role of advanced data technologies.

"With the help of big data and AI, disease surveillance and early warning systems can become more accurate and efficient," Yin said. "In the future, data-driven tools will enable precise assessments of vaccine protection efficacy."

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 国产成人刺激视频在线观看 | 欧美日韩中文字幕在线视频 | 青青草国产一区二区三区 | 国产主播福利片在线观看 | 免费人成黄页网站在线观看国产 | 性xxxx奶大欧美高清 | 亚洲日本中文字幕在线 | 免费看a级片| 国产人成午夜免视频网站 | 中文字幕日韩精品亚洲七区 | 亚洲欧美视频一区二区 | 久久综合日韩亚洲精品色 | 欧美日韩国产亚洲综合不卡 | 成 人 黄 色 激 情视频网站 | 996re免费热在线视频手机 | 亚洲国产精品一区二区不卡 | 玖草视频在线 | 亚洲综合伦理一区 | 久久久国产在线 | 久久久www成人免费精品 | 久久久久久久亚洲精品一区 | 欧美另类性视频 | 久久久视| 国产亚洲图片 | 欧美成人tv在线观看免费 | 免费播放国产性色生活片 | 国产成人99精品免费观看 | 成人午夜在线播放 | 亚洲国产精品成人综合久久久 | 国产三片高清在线观看 | 日本一区二区三区欧美在线观看 | 国产一国产一级毛片视频在线 | 欧美一级视 | 国产一级性片 | 一级成人毛片免费观看欧美 | 自拍偷拍亚洲区 | 国产亚洲欧美另类久久久 | 久草视屏| 中文字幕在线看视频一区二区三区 | 中文欧美一级强 | 国产一级在线 |